Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Pharmaceutical companies were dealt back-to-back blows over the last 24 hours in their fight against the Biden-era Medicare ...

An appeals panel found that a pharmaceutical company's participation in Medicare's drug price negotiation program is ...

Three federal courts reject legal challenges to Medicare drug price negotiation Judges side with government in cases filed by ...

The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation Program to the Fifth Circuit, returning the case to an appeals court that has ...

The drug price negotiation program has withstood another procedural effort in striking down one of the Inflation Reduction Act’s most significant provisions. | A federal court of appeals judge upheld ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

An appeals court has ruled against a legal challenge to the Drug Price Negotiation Program. On Wednesday, the U.S. Court of Appeals for the Sixth Circuit sided with the Department of Health and Human ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

The Health Resources and Services Administration (HRSA) issued a notice announcing the application process for the 340B rebate model pilot program ...